{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:07:03Z","timestamp":1783098423847,"version":"3.54.6"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81273484"],"award-info":[{"award-number":["81273484"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.jpba.2018.08.018","type":"journal-article","created":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T12:29:56Z","timestamp":1533904196000},"page":"404-414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Identification of hepatotoxic and nephrotoxic potential markers of triptolide in mice with delayed-type hypersensitivity"],"prefix":"10.1016","volume":"160","author":[{"given":"Zhe","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menglin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2018.08.018_bib0005","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.phymed.2006.01.010","article-title":"A systematic review of randomised clinical trials of Tripterygium wilfordii for rheumatoid arthritis","volume":"13","author":"Canter","year":"2006","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jpba.2018.08.018_bib0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jep.2014.06.006","article-title":"Triptolide: progress on research in pharmacodynamics and toxicology","volume":"155","author":"Li","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jpba.2018.08.018_bib0015","doi-asserted-by":"crossref","first-page":"e52454","DOI":"10.1371\/journal.pone.0052454","article-title":"Sphingolipids as new biomarkers for assessment of delayed-type hypersensitivity and response to triptolide","volume":"7","author":"Qu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jpba.2018.08.018_bib0020","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nm.3914","article-title":"The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment","volume":"21","author":"Zhang","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.jpba.2018.08.018_bib0025","first-page":"149","article-title":"Immunosuppressive, anti-inflammatory and anti-cancer properties of triptolide: a mini review","volume":"6","author":"Ziaei","year":"2016","journal-title":"Avicenna J. Phytomed."},{"key":"10.1016\/j.jpba.2018.08.018_bib0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.chroma.2005.02.083","article-title":"Determination of triptolide in root extracts of Tripterygium wilfordii by solid-phase extraction and reverse-phase high-performance liquid chromatography","volume":"1070","author":"Brinker","year":"2005","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2018.08.018_bib0035","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/ar.23293","article-title":"Anti- inflammatory and neuroprotective effects of triptolide via the NF-\u03baB signaling pathway in a rat MCAO mode","volume":"299","author":"Bai","year":"2016","journal-title":"Anat. Rec."},{"key":"10.1016\/j.jpba.2018.08.018_bib0040","first-page":"133","article-title":"Triptolide protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats: implication for immunosuppressive therapy in Parkinson\u2019s disease","volume":"24","author":"Gao","year":"2008","journal-title":"Anat. Rec."},{"key":"10.1016\/j.jpba.2018.08.018_bib0045","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jep.2015.05.010","article-title":"Integrated targeted sphingolipidomics and transcriptomics reveal abnormal sphingolipid metabolism as a novel mechanism of the hepatotoxicity and nephrotoxicity of triptolide","volume":"170","author":"Qu","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jpba.2018.08.018_bib0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.toxlet.2011.05.003","article-title":"Knockout of hepatic P450 reductase aggravates triptolide-induced toxicity","volume":"205","author":"Xue","year":"2011","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.jpba.2018.08.018_bib0055","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.etp.2011.03.013","article-title":"Involvement of oxidative stress in the mechanism of triptolide-induced acute nephrotoxicity in rats","volume":"64","author":"Yang","year":"2012","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.jpba.2018.08.018_bib0060","series-title":"National Center for ADR Monitoring of China, Notification of Drug Adverse Reactions (Issue 46) Concerns About the Safety of Tripterygium wilfordii Preparations","year":"2012"},{"key":"10.1016\/j.jpba.2018.08.018_bib0065","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2174\/1389200054021799","article-title":"A comprehensive listing of bioactivation pathways of organic functional groups","volume":"6","author":"Kalgutkar","year":"2005","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jpba.2018.08.018_bib0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1081\/DMR-200028812","article-title":"Drug bioactivation covalent binding to target proteins and toxicity relevance","volume":"37","author":"Zhou","year":"2005","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.jpba.2018.08.018_bib0075","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1021\/tx200168d","article-title":"Structural alert\/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States","volume":"24","author":"Stepan","year":"2011","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jpba.2018.08.018_bib0080","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1002\/rcm.5211","article-title":"Metabolite identification of triptolide by data\u2010dependent accurate mass spectrometric analysis in combination with online hydrogen\/deuterium exchange and multiple data\u2010mining techniques","volume":"25","author":"Du","year":"2011","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2018.08.018_bib0085","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/jat.2906","article-title":"Metabolic pathways leading to detoxification of triptolide, a major active component of the herbal medicine Tripterygium wilfordii","volume":"34","author":"Du","year":"2014","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.jpba.2018.08.018_bib0090","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jchromb.2013.08.015","article-title":"Metabolite profiling and identification of triptolide in rats","volume":"939","author":"Liu","year":"2013","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2018.08.018_bib0095","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jpba.2012.06.026","article-title":"Identification of in vivo and in vitro metabolites of triptolide by liquid chromatography\u2013tandem mass spectrometry","volume":"70","author":"Peng","year":"2012","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2018.08.018_bib0100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12906-016-1504-3","article-title":"Triptolide induces hepatotoxicity via inhibition of CYP450s in rat liver microsomes","volume":"17","author":"Lu","year":"2017","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.jpba.2018.08.018_bib0105","first-page":"893","article-title":"Low dose of resveratrol enhanced immune response of mice","volume":"23","author":"Feng","year":"2002","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jpba.2018.08.018_bib0110","doi-asserted-by":"crossref","first-page":"438","DOI":"10.2174\/0929867321666141112122118","article-title":"Should the incorporation of structural alerts be restricted in drug design? An analysis of structure-toxicity trends with aniline-based drugs","volume":"22","author":"Kalgutkar","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jpba.2018.08.018_bib0115","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00216-013-7479-8","article-title":"Lipidomic profiling of plasma in patients with chronic hepatitis C infection","volume":"406","author":"Qu","year":"2014","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2018.08.018_bib0120","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/jssc.200700644","article-title":"Hydrophilic interaction and reversed\u2010phase ultra\u2010performance liquid chromatography TOF\u2010MS for metabonomic analysis of Zucker rat urine","volume":"31","author":"Gika","year":"2008","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jpba.2018.08.018_bib0125","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jpba.2017.07.044","article-title":"Quality assurance procedures for mass spectrometry untargeted metabolomics. A review","volume":"147","author":"Dudzik","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2018.08.018_bib0130","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1373\/clinchem.2008.119396","article-title":"uPA+\/+ - SCID mouse with humanized liver as a model for in vivo metabolism of exogenous steroids: methandienone as a case study","volume":"55","author":"Lootens","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jpba.2018.08.018_bib0135","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.forsciint.2016.10.021","article-title":"Looking at flubromazolam metabolism from four different angles: metabolite profiling in human liver microsomes, human hepatocytes, mice and authentic human urine samples with liquid chromatography high-resolution mass spectrometry","volume":"274","author":"Wohlfarth","year":"2017","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2018.08.018_bib0140","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1365-2125.2010.03764.x","article-title":"Delayed drug hypersensitivity: models of T\u2010cell stimulation","volume":"71","author":"Adam","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2018.08.018_bib0145","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.4155\/fmc.14.114","article-title":"Pharmacophore modeling for COX-1 and-2 inhibitors with LigandScout in comparison to Discovery Studio","volume":"6","author":"Temml","year":"2014","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.jpba.2018.08.018_bib0150","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1089\/ars.2010.3830","article-title":"The cystine\/cysteine cycle and GSH are independent and crucial antioxidant systems in malignant melanoma cells and represent druggable targets","volume":"15","author":"Vene","year":"2011","journal-title":"Antioxid. Redox Signal."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708518306125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708518306125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T06:15:09Z","timestamp":1535782509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708518306125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":30,"alternative-id":["S0731708518306125"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2018.08.018","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of hepatotoxic and nephrotoxic potential markers of triptolide in mice with delayed-type hypersensitivity","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2018.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}